跳至主要内容
临床试验/ACTRN12619000010190
ACTRN12619000010190已完成未知

Investigating the effect of a novel brain stimulation treatment on episodic memory and gamma activity in Mild Alzheimer's Disease

Monash University0 个研究点目标入组 30 人开始时间: 2019年1月8日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
入组人数
30

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional
分配方式
Randomised controlled trial
主要目的
Treatment
盲法
Blinded (masking used)

入排标准

年龄范围
50 Years 至 85 Years(—)
性别
All

入选标准

  • Aged between 50-85 years
  • -Demonstrated ability to give informed consent
  • -Diagnosis of probable AD according to the National Institute of Neurological and Communication Disorders–Alzheimer’s Disease and Related Disorders Association (NINCDS–ADRDA) criteria
  • -Meet criteria for mild AD as indicated by a score of greater than 19 on the Mini-Mental State Evaluation (MMSE)
  • -Not on a cholinesterase inhibitor or memantine or have been on a stable dose for at least two months prior to screening
  • -Not on psychotropic medication or their dose of psychotropic medication has been unchanged for a minimum of 4 weeks prior to entry into the study
  • -Frequent contact with a caregiver who can provide information on the participant’s cognitive and functional abilities at study visits and assist with at home stimulation procedures where required
  • -Able to participate in cognitive testing in English

排除标准

  • -Concomitant major and unstable medical, psychiatric or neurological illness
  • -Pregnancy

研究者

相似试验